Global Hepatitis C Drugs Market Research Report 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 94

Report ID: 6682

Hepatitis is inflammation of the liver characterized by yellowed eyes and skin due to bilirubin, flu-like symptoms which include nausea, vomiting, poor appetite, joint pain, headaches, clay colored stools etc.
Hepatitis is caused by a variety of factors both microbial and non-microbial. However hepatitis C is caused by hepatitis C virus and affects between 130–150 million people globally every year of which approximately 700 000 people die from hepatitis C-related liver diseases. What is of greater concern is the fact that 15 to 20% of chronically infected patients develop liver cirrhosis or liver cancer.

The global Hepatitis C Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Hepatitis C Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hepatitis C Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Gilead sciences
Abbvi
Johnson & Johnson
Merck
Glaxosmithkline
Novartis
Bristol-Myers Squibb
Roche

Segment by Regions
North America
Europe
China
Japan

Segment by Type
By Drug Class
Anti-Viral
Immuno-modulators
Others
By Medicine System
Allopathic
Alternative
Others

Segment by Application
Hospitals
Clinics

Table of Contents

Executive Summary
1 Hepatitis C Drugs Market Overview
1.1 Product Overview and Scope of Hepatitis C Drugs
1.2 Hepatitis C Drugs Segment By Drug Class
1.2.1 Global Hepatitis C Drugs Production Growth Rate Comparison By Drug Class (2014-2025)
1.2.2 Anti-Viral
1.2.3 Immuno-modulators
1.2.4 Others
1.3 Hepatitis C Drugs Segment by Application
1.3.1 Hepatitis C Drugs Consumption Comparison by Application (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Hepatitis C Drugs Market by Region
1.4.1 Global Hepatitis C Drugs Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.4.6 Southeast Asia Status and Prospect (2014-2025)
1.4.7 India Status and Prospect (2014-2025)
1.5 Global Hepatitis C Drugs Market Size
1.5.1 Global Hepatitis C Drugs Revenue (2014-2025)
1.5.2 Global Hepatitis C Drugs Production (2014-2025)

2 Global Hepatitis C Drugs Market Competition by Manufacturers
2.1 Global Hepatitis C Drugs Production Market Share by Manufacturers (2014-2019)
2.2 Global Hepatitis C Drugs Revenue Share by Manufacturers (2014-2019)
2.3 Global Hepatitis C Drugs Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Hepatitis C Drugs Production Sites, Area Served, Product Types
2.5 Hepatitis C Drugs Market Competitive Situation and Trends
2.5.1 Hepatitis C Drugs Market Concentration Rate
2.5.2 Hepatitis C Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Hepatitis C Drugs Production Market Share by Regions
3.1 Global Hepatitis C Drugs Production Market Share by Regions
3.2 Global Hepatitis C Drugs Revenue Market Share by Regions (2014-2019)
3.3 Global Hepatitis C Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Hepatitis C Drugs Production
3.4.1 North America Hepatitis C Drugs Production Growth Rate (2014-2019)
3.4.2 North America Hepatitis C Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Hepatitis C Drugs Production
3.5.1 Europe Hepatitis C Drugs Production Growth Rate (2014-2019)
3.5.2 Europe Hepatitis C Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Hepatitis C Drugs Production (2014-2019)
3.6.1 China Hepatitis C Drugs Production Growth Rate (2014-2019)
3.6.2 China Hepatitis C Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Hepatitis C Drugs Production (2014-2019)
3.7.1 Japan Hepatitis C Drugs Production Growth Rate (2014-2019)
3.7.2 Japan Hepatitis C Drugs Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Hepatitis C Drugs Consumption by Regions
4.1 Global Hepatitis C Drugs Consumption by Regions
4.2 North America Hepatitis C Drugs Consumption (2014-2019)
4.3 Europe Hepatitis C Drugs Consumption (2014-2019)
4.4 China Hepatitis C Drugs Consumption (2014-2019)
4.5 Japan Hepatitis C Drugs Consumption (2014-2019)

5 Global Hepatitis C Drugs Production, Revenue, Price Trend by Type
5.1 Global Hepatitis C Drugs Production Market Share by Type (2014-2019)
5.2 Global Hepatitis C Drugs Revenue Market Share by Type (2014-2019)
5.3 Global Hepatitis C Drugs Price by Type (2014-2019)
5.4 Global Hepatitis C Drugs Production Growth by Type (2014-2019)

6 Global Hepatitis C Drugs Market Analysis by Applications
6.1 Global Hepatitis C Drugs Consumption Market Share by Application (2014-2019)
6.2 Global Hepatitis C Drugs Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Hepatitis C Drugs Business
7.1 Gilead sciences
7.1.1 Gilead sciences Hepatitis C Drugs Production Sites and Area Served
7.1.2 Hepatitis C Drugs Product Introduction, Application and Specification
7.1.3 Gilead sciences Hepatitis C Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Abbvi
7.2.1 Abbvi Hepatitis C Drugs Production Sites and Area Served
7.2.2 Hepatitis C Drugs Product Introduction, Application and Specification
7.2.3 Abbvi Hepatitis C Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Hepatitis C Drugs Production Sites and Area Served
7.3.2 Hepatitis C Drugs Product Introduction, Application and Specification
7.3.3 Johnson & Johnson Hepatitis C Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Merck
7.4.1 Merck Hepatitis C Drugs Production Sites and Area Served
7.4.2 Hepatitis C Drugs Product Introduction, Application and Specification
7.4.3 Merck Hepatitis C Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Glaxosmithkline
7.5.1 Glaxosmithkline Hepatitis C Drugs Production Sites and Area Served
7.5.2 Hepatitis C Drugs Product Introduction, Application and Specification
7.5.3 Glaxosmithkline Hepatitis C Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Novartis
7.6.1 Novartis Hepatitis C Drugs Production Sites and Area Served
7.6.2 Hepatitis C Drugs Product Introduction, Application and Specification
7.6.3 Novartis Hepatitis C Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Bristol-Myers Squibb
7.7.1 Bristol-Myers Squibb Hepatitis C Drugs Production Sites and Area Served
7.7.2 Hepatitis C Drugs Product Introduction, Application and Specification
7.7.3 Bristol-Myers Squibb Hepatitis C Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 Roche
7.8.1 Roche Hepatitis C Drugs Production Sites and Area Served
7.8.2 Hepatitis C Drugs Product Introduction, Application and Specification
7.8.3 Roche Hepatitis C Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served

8 Hepatitis C Drugs Manufacturing Cost Analysis
8.1 Hepatitis C Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Hepatitis C Drugs
8.4 Hepatitis C Drugs Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Hepatitis C Drugs Distributors List
9.3 Hepatitis C Drugs Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Hepatitis C Drugs Market Forecast
11.1 Global Hepatitis C Drugs Production, Revenue Forecast
11.1.1 Global Hepatitis C Drugs Production Growth Rate Forecast (2019-2025)
11.1.2 Global Hepatitis C Drugs Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Hepatitis C Drugs Price and Trend Forecast (2019-2025)
11.2 Global Hepatitis C Drugs Production Forecast by Regions (2019-2025)
11.2.1 North America Hepatitis C Drugs Production, Revenue Forecast (2019-2025)
11.2.2 Europe Hepatitis C Drugs Production, Revenue Forecast (2019-2025)
11.2.3 China Hepatitis C Drugs Production, Revenue Forecast (2019-2025)
11.2.4 Japan Hepatitis C Drugs Production, Revenue Forecast (2019-2025)
11.3 Global Hepatitis C Drugs Consumption Forecast by Regions (2019-2025)
11.3.1 North America Hepatitis C Drugs Consumption Forecast (2019-2025)
11.3.2 Europe Hepatitis C Drugs Consumption Forecast (2019-2025)
11.3.3 China Hepatitis C Drugs Consumption Forecast (2019-2025)
11.3.4 Japan Hepatitis C Drugs Consumption Forecast (2019-2025)
11.4 Global Hepatitis C Drugs Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Hepatitis C Drugs Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer